(Q45984532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Andreas Peyrl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Robert Sauermann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Friederike Traunmueller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mariella Gruber-Olipitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Astrid Gupper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Irene Slavc

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

265-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19492871%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-200948040-00004

29 January 2020

exact match

0 references

cites work

Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200948040-00004

Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200948040-00004

The mechanism of cytosine arabinoside toxicity on quiescent astrocytes in vitro appears to be analogous to in vivo brain injury

21 January 2018

1 reference

12 December 2020

Extended CSF cytarabine exposure following intrathecal administration of DTC 101.

1 reference

12 December 2020

A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study

1 reference

12 December 2020

Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy

1 reference

12 December 2020

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis

1 reference

12 December 2020

Cytosine arabinoside cerebrospinal fluid kinetics

1 reference

12 December 2020

Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis

1 reference

12 December 2020

Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells

1 reference

12 December 2020

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

12 December 2020

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

1 reference

12 December 2020

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

1 reference

12 December 2020

Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics

1 reference

12 December 2020

The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells

1 reference

12 December 2020

Formation and absorption of cerebrospinal fluid in man

1 reference

12 December 2020